Bosutris 400

Name: Bosutris 400
Brand: PATHGENE PHARMA DISTRIBUTORS
Price: 5400 INR
Availability: InStock

Price 5400 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Bosutris 400 Specification

Indication
Used for treatment of chronic myeloid leukemia (CML)

Dosage Form
Tablet

Salt Composition
Bosutinib 400 mg

Enzyme Types
Not applicable (Bosutinib is a tyrosine kinase inhibitor, not an enzyme)

Feature

Ingredients
Bosutinib and excipients

Application
Oral administration for patients with Philadelphia chromosome-positive chronic myeloid leukemia

Physical Color/Texture
Solid tablet form

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
As mentioned on packaging (typically 24-36 months from manufacture)

Packaging Size
30 Tablets per box

Prescription Status
Prescription required

Therapeutic Class
Anticancer, Tyrosine Kinase Inhibitor

Route of Administration
Oral

Strength
400 mg per tablet

Storage Type
Ambient

Brand Name
Bosutris 400

Common Side Effects
Diarrhea, nausea, abdominal pain, rash, liver enzyme abnormalities

Intended Patient
Adults with Philadelphia chromosome-positive chronic myelogenous leukemia

Contraindications
Hypersensitivity to Bosutinib or any excipients

Bosutris 400 Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Boxes Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Bosutris 400

Experience the terrific power of Bosutris 400-your fresh option in targeted oral chemotherapy for Philadelphia chromosome-positive chronic myeloid leukemia (CML) in adults. Each solid tablet delivers a valuable 400 mg dose of Bosutinib, designed for high efficacy as a tyrosine kinase inhibitor. Packaged elegantly in boxes of 30 tablets, Bosutris 400 ensures reduced adverse effects when taken as prescribed, with common mild side effects including diarrhea and nausea. Prescription required. Store below 30C and protect from moisture for optimal shelf life. Try Bosutris 400 now for a gorgeous blend of potency and precision in cancer care.

Bosutris 400: Commercial Uses and Special Features

Bosutris 400 is critically utilized for the treatment of chronic myeloid leukemia (CML) in adults, providing a high-potency oral therapeutic option. It stands out due to its targeted mode of action as a tyrosine kinase inhibitor, which can result in reduced off-target effects. The solid tablet form ensures convenience while its valuable stability at ambient temperatures makes it ideal for clinical use. With prescription-only access, Bosutris 400 delivers trustworthy performance in oncology practice.

Bosutris 400: Domestic and Export Markets, Sample Availability

Bosutris 400 enjoys a robust presence in India's main domestic pharmaceutical market and is also dispatched to several major export destinations. Suppliers offer quick dispatch and streamlined exporting, reducing both time and expenditure for healthcare providers. Sample tablets are readily available for evaluation, catering to supplier and trader needs. Fast and efficient dispatching, paired with comprehensive market reach, makes Bosutris 400 a preferred choice in oncology care internationally.

FAQ's of Bosutris 400:

Q: How should Bosutris 400 be stored for maximum shelf life?

A: Bosutris 400 should be stored at ambient temperatures below 30C, away from moisture and direct light, as stated on the packaging. This ensures the tablets maintain their potency throughout their shelf life, typically 24 to 36 months from manufacture.

Q: What is the main usage of Bosutris 400?

A: Bosutris 400 is primarily used for the oral treatment of adults diagnosed with chronic myeloid leukemia (CML) that is Philadelphia chromosome positive, helping to control the progression of the disease.

Q: When is Bosutris 400 contraindicated?

A: Bosutris 400 should not be used by individuals with hypersensitivity to Bosutinib or any of its excipients to avoid potential adverse reactions. Always consult your healthcare provider before starting therapy.

Q: Where can I obtain Bosutris 400?

A: Bosutris 400 is available through authorized suppliers and traders in India and can be accessed with a valid prescription. It is also exported to international markets through certified pharmaceutical distributors.

Q: What are the benefits of choosing Bosutris 400 in cancer therapy?

A: Bosutris 400 offers targeted action as a tyrosine kinase inhibitor, providing a high-potency and convenient oral option for CML management. Its solid form and ambient storage improve patient compliance and streamline handling for providers.

Tell us about your requirement